UPDATE 2-FDA panel backs Teva's abuse-resistant opioid painkiller

June 7 (Reuters) - A U.S. advisory panel recommended

approving Teva Pharmaceuticals Industries Ltd's

long-acting opioid painkiller, Vantrela ER, saying data

showed it reduces pain and has some...

Read more